Amount Raised
$32.5 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
Oak Hill Bio has successfully secured $32.5 million in a Series A funding round. This investment will help the company advance its innovative projects in the pharmaceutical sector. The funding will enhance their research and development capabilities. The round marks a significant milestone for Oak Hill Bio.
Quick answer
Oak Hill Bio raised $32.5 Million in a Series A round, dated June 1, 2026. Investors: KCap Biotechnology Fund, Janus Henderson and Balyasny Asset Management. Oak Hill Bio is based in Cambridge, Massachusetts, United States.
- How much did Oak Hill Bio raise?
- Oak Hill Bio raised $32.5 Million in a Series A round on June 1, 2026.
- Who invested in Oak Hill Bio?
- KCap Biotechnology Fund, Janus Henderson and Balyasny Asset Management are named as investors in this round.
- What does Oak Hill Bio do?
- Oak Hill Bio is a clinical-stage neonatology and rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases.
- Where is Oak Hill Bio based and how big is it?
- Oak Hill Bio is based in Cambridge, Massachusetts, United States. Fundz records about 29 employees.
- Who are the decision-makers at Oak Hill Bio?
- Fundz holds 1 contact at Oak Hill Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Oak Hill Bio that raised within 45 days of this round, from Fundz verified event records.
- Georgiamune raised $93M on July 16, 2026.
- Crescent Biopharma raised $8.1M (Post-IPO Equity) on July 15, 2026.
- AdvanCell raised $315M (Series D) on July 15, 2026.
- Draig Therapeutics raised $65M (Series B) on July 14, 2026.
- Cue Biopharma raised $50M on July 13, 2026.
- Privo Technologies raised $1.2M (Grant) on July 12, 2026.
Who to call at Oak Hill Bio, and when
A new round usually means Oak Hill Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Oak Hill Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oak Hill Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oak Hill Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oak Hill Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansOak Hill Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.